Menu
Back to User profile » Professor Jung Mi Oh
Papers published by Professor Jung Mi Oh:
Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
Han N, Oh JM, Kim IW
Therapeutics and Clinical Risk Management 2021, 17:877-887
Published Date: 21 August 2021
Potentially Inappropriate Prescriptions to Older Patients in Emergency Departments in South Korea: A Retrospective Study
Kim K, Jung J, Kim H, Kim JT, Oh JM, Kim H
Therapeutics and Clinical Risk Management 2021, 17:173-181
Published Date: 19 February 2021
CYP3A5 genotype-based model to predict tacrolimus dosage in the early postoperative period after living donor liver transplantation
Ji E, Kim MG, Oh JM
Therapeutics and Clinical Risk Management 2018, 14:2119-2126
Published Date: 25 October 2018
Impact of depression on change in coronary heart disease risk status: the Korean Genome and Epidemiology Study (KoGES)
Jang HY, Song YK, Kim JH, Kim MG, Han N, Lee HY, Kim IW, Oh JM
Therapeutics and Clinical Risk Management 2018, 14:121-128
Published Date: 10 January 2018
Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation
Han N, Han SH, Song YK, Kim MG, Kim YS, Kim IW, Oh JM
Therapeutics and Clinical Risk Management 2017, 13:1513-1520
Published Date: 21 November 2017
Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial
Han N, Hong SH, Kim YS, Kim DK, Kim IW, Ji E, Oh JM
Therapeutics and Clinical Risk Management 2017, 13:999-1007
Published Date: 14 August 2017
Satisfaction and expressed needs of pharmaceutical care services and challenges recognized by patients in South Korea
Kang J, Rhew K, Oh JM, Han N, Lee IH, Je NK, Ji E, Lee E, Yoon J, Rhie SJ
Patient Preference and Adherence 2017, 11:1381-1388
Published Date: 11 August 2017
Meta-analysis of the impact of thioprine S-methyltransferase polymorphisms on the tolerable 6-mercaptopurine dose considering initial dose and ethnic difference
Kim MG, Ko M, Kim IW, Oh JM
OncoTargets and Therapy 2016, 9:7133-7139
Published Date: 18 November 2016
Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
Jeong S, Kim IW, Oh KH, Han N, Joo KW, Kim HJ, Oh JM
Drug Design, Development and Therapy 2016, 10:2211-2225
Published Date: 8 July 2016
Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review
Jeong S, Kim JH, Kim MG, Han N, Kim IW, Kim T, Oh JM
OncoTargets and Therapy 2016, 9:655-669
Published Date: 9 February 2016